AI assistance in tumor treatment meetings
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This study tests whether a large language model can help doctors make better decisions in tumor multidisciplinary team meetings. It evaluates junior doctors with specific experience levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a junior doctor with a practice license.
- You are an oncologist, surgeon, radiation oncologist, radiologist, or pathologist with 3 to 5 years of experience.
- You are between 25 and 33 years old.
- You can commit to at least 10 hours during the study.
- You have not been involved in treating any of the 20 cases used in this research.
- You agree to join and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares treatment recommendations from a computer system with those from a team of cancer doctors. It may help improve how cancer care decisions are made.
This trial is looking at whether artificial intelligence can make treatment decisions as well as a team of cancer experts. If you have colorectal cancer and have been seen by the cancer experts at Peking University Cancer Hospital, your medical records may help answer this question.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This trial tests whether artificial intelligence can help doctors plan better treatment for non-small cell lung cancer (NSCLC). A team of specialists will use AI tools alongside their usual approach to see if it improves care and safety.
This study tests an artificial intelligence (AI) helper that assists doctors in managing thyroid cancer. It aims to see if the tool can improve care for patients like you.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.